Page last updated: 2024-09-04

3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine and Pulmonary Hypertension

3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine has been researched along with Pulmonary Hypertension in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnal, F; Hill, NS; Klinger, JR; Petit, RD; Warburton, RR; Wrenn, DS1

Other Studies

1 other study(ies) available for 3-amino-2-methyl-8-phenylmethoxyimidazo(1,2-a)pyrazine and Pulmonary Hypertension

ArticleYear
Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats.
    Journal of applied physiology (Bethesda, Md. : 1985), 1993, Volume: 75, Issue:4

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Cyclic GMP; Dioxolanes; Dipeptides; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Imidazoles; Male; Muscle, Smooth, Vascular; Myocardium; Neprilysin; Pyrazines; Rats; Rats, Sprague-Dawley; RNA, Messenger

1993